Galmed Pharmaceuticals Ltd. (GLMD) is a publicly traded Healthcare sector company. As of May 21, 2026, GLMD trades at $0.60 with a market cap of $3.85M and a P/E ratio of 0.00. GLMD moved +7.88% today. Year to date, GLMD is -28.31%; over the trailing twelve months it is -55.91%. Its 52-week range spans $0.41 to $7.76. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces GLMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Galmed Pharmaceuticals Ltd. (GLMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GLMD moved +7.88% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $0.60 |
| Market Cap | $3.85M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.76 |
| 52-Week Low | $0.41 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover GLMD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.